Home Events - HRC Fertility Event Seminar 5/23/2025: Free AMH Testing Event With Dr. Waud at HRC Fertility San Francisco
Infertility 101 Seminars and Webinars at HRC Fertility

5/23/2025: Free AMH Testing Event With Dr. Waud at HRC Fertility San Francisco

May 23, 2025
HRC Fertility San Francisco
12:00 – 2:00 PM

Curious About Your Fertility? Let’s Check!

Join Us for a Free AMH Testing Event at HRC Fertility San Francisco

​Your hormones can reveal a lot about your fertility health. Join HRC Fertility for a FREE AMH blood test — simple, quick, and insightful. Don’t miss the opportunity to mingle with Dr. Kay Waud, who’ll be there to answer your questions

Whether you’re planning for the future or just seeking more information, the AMH test is a helpful tool to help you make informed decisions about your reproductive health.

What’s included:

  • Free AMH (Anti-Müllerian Hormone) Test
  • Personalized phone call with Dr. Kay Waud to discuss your results
  • Education and resources to help you understand your fertility potential
  • Live Q&A with Dr. Waud

Ideal for:
Anyone 23–44 curious about their fertility and hormonal health.

Sign Up:
Complete the patient form <HERE> to book your spot. You’ll receive your time slot (12–2 PM) and HIPAA forms through EngagedMD to sign before the event.

​Participants will be offered an exclusive $99 consultation to review their results. Questions? Call 415-287-6981.

Space is limited, so reserve your spot now!

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

May 23 2025

Time

12:00 pm - 2:00 pm

Location

San Francisco
55 Francisco St., San Francisco, CA 94133

Category

Organizer

Dr. Kay Waud
Dr. Kay Waud
Website
https://www.havingbabies.com/physicians/kay-waud-md-facog/

Kay Waud, MD, PhD, FACOG is a double board-certified physician specializing in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She takes a special interest in fertility preservation, recurrent pregnancy loss, and improving fertility outcomes in patients with diminished ovarian reserve.